Literature DB >> 18936714

The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: role of asymmetric dimethylarginine.

Zhe Zhang1, Yi-You Zou, Yuan Zhou, Hui Zhou, Yuan-Jian Li.   

Abstract

BACKGROUND AND GOAL: Nitric oxide (NO) is a well-known gastric mucosa protection factor. Recently, it has been reported that methylated arginine compound such as asymmetric dimethylarginine (ADMA), which inhibits nitric oxide synthesis, may be related to the development of gastric mucosa injury in patients with Helicobacter pylori infection. In the present study, we tested the relationship between endogenous ADMA and gastric mucosa injury in H. pylor- infected patients and cultured gastric epithelial cells.
METHODS: One hundred and fifty subjects with gastric diseases were entered in this study. The levels of ADMA in gastric juice and plasma were measured in both H. pylori+ and H. pylori- patients. We analyzed independent risk factors that contribute to ADMA levels by multiple linear regression analyses. Mucosal epithelium cells were treated with nicotine (10 microM) for 24 hours in the presence or absence of H. pylori. The concentrations of ADMA in the culture medium and the rate of cell apoptosis were determined.
RESULTS: The ADMA level in gastric juice was significantly increased in H. pylori+ patients (P<0.05), whereas there were no differences in the content of ADMA in the plasma between H. pylori+ patients and H. pylori- patients. Smoking and H. pylori infection were 2 independent risk factors contributing to ADMA levels, and in the population of H. pylori+ patients, the level of ADMA in smokers was higher compared with nonsmokers. Incubation of nicotine (10 microM) with epithelial cells for 24 hours further increased the elevated level of ADMA and the rate of cell apoptosis owing to H. pylori infection.
CONCLUSIONS: H. pylori infection caused an increase of ADMA levels in gastric juice, which was aggravated by smoking. Endogenous ADMA may be an important factor contributing to gastric mucosa injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18936714     DOI: 10.1097/MCG.0b013e3181624485

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

Review 1.  Asymmetric dimethylarginine: a novel biomarker of gastric mucosal injury?

Authors:  Zhe Zhang; Yi-You Zou; Fu-Jun Li; Chang-Ping Hu
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.

Authors:  Mark G O'Doherty; Sarah E C M Gilchrist; Ian S Young; Michelle C McKinley; John W G Yarnell; K Fred Gey; Alun Evans; Paula M L Skidmore; Jayne V Woodside
Journal:  Eur J Nutr       Date:  2010-04-18       Impact factor: 5.614

3.  Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.

Authors:  Selim Aydemir; Haci Eren; Ishak Ozel Tekin; Ferda Akbay Harmandar; Nejat Demircan; Mehmet Cabuk
Journal:  Mediators Inflamm       Date:  2010-12-13       Impact factor: 4.711

4.  Role of caspase-3/E-cadherin in helicobacter pylori-induced apoptosis of gastric epithelial cells.

Authors:  Yongmei Yang; Jie Du; Fen Liu; Xiaoyan Wang; Xiaohui Li; Yuanjian Li
Journal:  Oncotarget       Date:  2017-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.